The nation of Zimbabwe has turned down a major American health deal worth 367 million US dollars (£272m) over five years over Washington's insistence on sensitive information.
This rejection became public following a government memo dated December was disclosed, which showed President Emmerson Mnangagwa deemed the deal was "skewed".
An official spokesman later explained that the United States was seeking health data for scientific study and commercial purposes while was unwilling to share the benefits from any future medical innovations.
"We must now begin the difficult and regrettable task of scaling back our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the United States had furnished over $1.9bn in health funding to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has appealed for continued dialogue to find a agreement suitable to both sides so the country's critical HIV programme can proceed.
Wider Context
This development comes after a comparable case in neighbouring Kenya, where a high court suspended a related health funding agreement following legal challenges were filed about the safety of Kenyans' medical information.
Since returning to office last year, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).
USAID had administered aid for the US government, but Trump argued its spending was "inefficient" and his government was pursuing government-to-government agreements to enhance transparency and accountability.
Based on statements, Sixteen nations in Africa have so far agreed to these new agreements, representing more than $18.3bn of fresh investment.
Details of the Rejected Deal
The funds for Zimbabwe would have gone towards "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this collaboration would have delivered immense benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on antiretroviral therapy through US-supported programmes," the Ambassador said.
However, official spokesman Nick Mangwana maintained the proposed deal was "asymmetrical".
"Zimbabwe was being asked to surrender its genetic material and health information over an extended period, with no corresponding assurance of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," Mangwana explained.
"Effectively, our nation would supply the raw materials for scientific discovery with no certainty that the resulting innovations would be accessible to our population should a new health crisis emerge."
National Interest and Global Health
Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were upending systems previously set up via the global health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system created to deal with potential global health emergencies.
"This system is intended to ensure that when a nation contributes its information, the benefits – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the funds to create them."
Zimbabwe's reservations over the US deal "should not be misconstrued as opposition to America," Mangwana stressed.
"We are open to continued discussions with our US partners on how subsequent co-operation could be designed in a way that respects the independence and dignity of each country."
Medical Community Response
A leading public health body said it understood the official position, but suggested that negotiations should continue since a large portion of the nation's HIV programmes relied on external financing.
"Where specific concerns exist, such as those involving data governance or implementation frameworks, these can often be addressed via detailed discussion and negotiated safeguards," it commented.
This impasse highlights the complex tensions between accepting much-needed international aid and protecting national sovereignty in an ever more interconnected world.